These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17554405)

  • 1. Treatment options for hormone-refractory prostate cancer.
    Chang SS
    Rev Urol; 2007; 9 Suppl 2(Suppl 2):S13-8. PubMed ID: 17554405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current standard and investigational approaches to the management of hormone-refractory prostate cancer.
    Mendiratta P; Armstrong AJ; George DJ
    Rev Urol; 2007; 9 Suppl 1(Suppl 1):S9-S19. PubMed ID: 17387372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update in the management of patients with hormone-refractory prostate cancer.
    Moore CN; George DJ
    Curr Opin Urol; 2005 May; 15(3):157-62. PubMed ID: 15815191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinoma.
    Chang SS; Benson MC; Campbell SC; Crook J; Dreicer R; Evans CP; Hall MC; Higano C; Kelly WK; Sartor O; Smith JA;
    Cancer; 2005 Jan; 103(1):11-21. PubMed ID: 15558815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Southwest Oncology Group studies in hormone-refractory prostate cancer.
    Hussain MH; Blumenstein B; Eisenberger M; Crawford ED
    Semin Oncol; 1996 Dec; 23(6 Suppl 14):24-7. PubMed ID: 8996581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for the treatment of hormone-refractory prostate cancer.
    Chowdhury S; Burbridge S; Harper PG
    Int J Clin Pract; 2007 Dec; 61(12):2064-70. PubMed ID: 17956560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic chemotherapy for prostate cancer: Who and when?
    Moss RA; Petrylak DP
    Curr Treat Options Oncol; 2006 Sep; 7(5):370-7. PubMed ID: 16904054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Options of Chemotherapy in the Treatment of Prostate Cancer].
    Richter I; Dvořák J; Bartoš J
    Klin Onkol; 2017; 30(1):28-33. PubMed ID: 28185462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment options for hormone-refractory prostate cancer].
    Heidenreich A; Ohlmann CH
    Urologe A; 2005 Nov; 44(11):1303-4, 1306-14. PubMed ID: 16237541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel in hormone-refractory metastatic prostate cancer.
    McKeage K; Keam SJ
    Drugs; 2005; 65(16):2287-94; discussion 2295-7. PubMed ID: 16266195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy in hormone-refractory prostate cancer.
    de Wit R
    BJU Int; 2008 Mar; 101 Suppl 2():11-5. PubMed ID: 18307687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options for hormone-refractory prostate cancer in 2007.
    Hadaschik BA; Gleave ME
    Urol Oncol; 2007; 25(5):413-9. PubMed ID: 17826663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current role of chemotherapy in metastatic hormone-refractory prostate cancer.
    Petrylak DP
    Urology; 2005 May; 65(5 Suppl):3-7; discussion 7-8. PubMed ID: 15885271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Hormone-Sensitive and Hormone-Refractory Metastatic Prostate Cancer.
    Rago R
    Cancer Control; 1998 Nov; 5(6):513-521. PubMed ID: 10761100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-based treatment for castration-resistant prostate cancer.
    Seruga B; Tannock IF
    J Clin Oncol; 2011 Sep; 29(27):3686-94. PubMed ID: 21844499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.
    Berry W; Eisenberger M
    Oncologist; 2005; 10 Suppl 3():30-9. PubMed ID: 16368869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone-refractory prostate cancer: where are we going?
    Di Lorenzo G; Autorino R; Figg WD; De Placido S
    Drugs; 2007; 67(8):1109-24. PubMed ID: 17521214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer.
    Berry WR
    Urology; 2005 Jun; 65(6 Suppl):2-7. PubMed ID: 15939076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An interdisciplinary approach to treating prostate cancer.
    Kibel AS
    Urology; 2005 Jun; 65(6 Suppl):13-8. PubMed ID: 15939078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hormone refractory prostate cancer: current standards and future prospects.
    Oh WK; Kantoff PW
    J Urol; 1998 Oct; 160(4):1220-9. PubMed ID: 9751323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.